ArticleCurrent oncology (Toronto, Ont.)2026
Metastatic Tumour Burden as Prognostic Factor in Nivolumab-Treated Metastatic Renal Cell Carcinoma: An Exploratory Study.
Mario Uccello et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.